The popularity of Viagra initially fueled a boom for pharma, however recent shifts present a murky outlook for shareholders. Lower-cost alternatives are eating into earnings, and continued legal battles add more https://jemimafxsd376361.blog5.net/92898734/viagra-and-pharma-a-risky-bet